The field of biological medicines is an exciting and rapidly changing area of drug development. Many existing biological drugs have already transformed the lives of patients living with life-limiting and debilitating diseases. Innovative approaches that leverage single-cell analysis platforms are removing significant barriers and boosting productivity within complex cell line development processes to transform the delivery of novel biotherapeutic molecules. Dr Fay Saunders at FUJIFILM Diosynth Biotechnologies explains how such advances are enabling biopharmaceutical companies to swiftly transition from the initial transfection phase through to the development of highly productive cell lines.
[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2019/07/Enhansing-cell-line-development-and-streamlining.pdf” width=”100%” height=”900px” style=”border:0;”]